The PRIMERO study tracks biomarkers that can predict asthma in children starting at birth to help with early interventions in treatment and prevention.
Our webinar speakers explored the state of COVID-19 and asthma care as of June 2020 and discussed the potential future for schools and businesses.
Dr. John Oppenheimer reviewed biologic medications that are changing asthma and allergy care providing more personalized options for treatment.
The presenter discusses the prevalence of allergic reactions to cannabis (marijuana); information on diagnosis & management; benefits & harms.
Read a summary of the 2020 virtual AADCH event and learn about priority legislative & regulatory issues for patients living with asthma & allergies.